InvestorsHub Logo

Magnum7419

08/02/15 10:18 AM

#130826 RE: Crusen #130825

What is your basis for a decline in price as we approach Q2 earnings date. All filings and PR show the business is improving on all levels and the toxic financing by Dominion has been replaced with 2 million dollars from 3 accredited investors with an equity line to back that up if needed.

Last filing on March showed IVXX was an asset on the balance sheet at the tune of 794,000 after only 90 days of operation. At that time they had a distribution line of only 5 dispensaries. Now they have over 30 dispensaries. Common sense says that asset is improving.

Since last filing EG has added almost 500 stores to their distribution and or a 50% increase in customer base coupled with an increase in gross margin from .02 to .30%. Common sense says their numbers will have improved as well as future guidance.

Since last filing EG was given 300,000 dollar grant at a rate of 21,000 a month for the next nine months. Common sense says that should improve the bottom line.

The last filing showed total liabilites had been reduced by 50% since Sept of 2014 (5 million dollars) Common sense says share dilution is over.

I yield to your due diligence.